JP2010525055A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010525055A5 JP2010525055A5 JP2010506110A JP2010506110A JP2010525055A5 JP 2010525055 A5 JP2010525055 A5 JP 2010525055A5 JP 2010506110 A JP2010506110 A JP 2010506110A JP 2010506110 A JP2010506110 A JP 2010506110A JP 2010525055 A5 JP2010525055 A5 JP 2010525055A5
- Authority
- JP
- Japan
- Prior art keywords
- corm
- medicament
- manufacture
- treatment
- infectious diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92597607P | 2007-04-24 | 2007-04-24 | |
| PCT/PT2008/000017 WO2008130261A1 (en) | 2007-04-24 | 2008-04-24 | Treatment of infections by carbon monoxide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010525055A JP2010525055A (ja) | 2010-07-22 |
| JP2010525055A5 true JP2010525055A5 (enExample) | 2012-06-28 |
Family
ID=39720470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010506110A Pending JP2010525055A (ja) | 2007-04-24 | 2008-04-24 | 一酸化炭素による感染症の処置 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20100196516A1 (enExample) |
| EP (1) | EP2148688A1 (enExample) |
| JP (1) | JP2010525055A (enExample) |
| WO (1) | WO2008130261A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0111872D0 (en) * | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
| CA2475209A1 (en) | 2002-02-04 | 2003-08-14 | Alfama - Investigacao E Desenvolvimento De Produtos Farmaceuticos Lda. | Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases |
| US7968605B2 (en) | 2002-02-04 | 2011-06-28 | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| GB2395432B (en) | 2002-11-20 | 2005-09-14 | Northwick Park Inst For Medica | Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
| US20070207217A1 (en) * | 2003-02-03 | 2007-09-06 | Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda | Method for treating a mammal by administration of a compound having the ability to release CO |
| JP2007501209A (ja) * | 2003-08-04 | 2007-01-25 | ノースウィック パーク インスティテュート フォー メディカル リサーチ | 一酸化炭素の治療目的での放出のためのボラノカルボネートの使用 |
| GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
| EP2182961B1 (en) * | 2007-07-24 | 2012-05-02 | Alfama - Investigaçao e Desenvolvimento de Productos Farmaceuticos LDA. | Prevention of gastric ulcery by carbon monoxide |
| ES2656237T3 (es) | 2011-04-19 | 2018-02-26 | Alfama, Inc. | Moléculas liberadoras de monóxido de carbono y usos de las mismas |
| WO2013013179A1 (en) | 2011-07-21 | 2013-01-24 | Alfama, Inc. | Ruthenium carbon monoxide releasing molecules and uses thereof |
| DE102014008685A1 (de) * | 2014-06-13 | 2015-12-17 | Lorenz Meinel | Freisetzungssystem für therapeutisches Gas |
| US10314860B2 (en) | 2015-05-21 | 2019-06-11 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods for treating and preventing venom related poisoning |
| WO2017015344A1 (en) * | 2015-07-20 | 2017-01-26 | University Of Vermont And State Agricultural College | Use of cymanquine compounds as antimalarial agents |
| EP3524290A1 (en) | 2018-02-09 | 2019-08-14 | Julius-Maximilians-Universitaet Wuerzburg | Method and system for monitoring carbon monoxide (co) administration to ex-vivo fluids |
| EP3808351A1 (en) | 2019-10-14 | 2021-04-21 | Julius-Maximilians-Universität Würzburg | Membrane-based two component therapeutic gas release system for oral administration |
| EP3878471A1 (en) | 2020-03-13 | 2021-09-15 | Julius-Maximilians-Universitaet Wuerzburg | Therapeutic system for the topic, transdermal and transcutaneous application of carbon monoxide |
| EP4275682A1 (en) * | 2022-05-12 | 2023-11-15 | Institut National De La Sante Et De La Recherche Medicale - Inserm | Carbon monoxide-releasing molecule (corm) or composition thereof for use in the treatment or the prevention of an intestinal dysbiosis in a subject |
| WO2024052568A1 (en) | 2022-09-09 | 2024-03-14 | Julius-Maximilians-Universität Würzburg | Receptacle, device for releasing carbon monoxide, treatment system, set for treating living cells, method of treating a mammal, and carbon monoxideξ |
| CN119157883B (zh) * | 2024-11-15 | 2025-02-14 | 温州医科大学附属口腔医院 | 一种抗菌剂及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3065250A (en) * | 1960-05-13 | 1962-11-20 | Hercules Powder Co Ltd | Nitrile-metal carbonyl complexes |
| US4792452A (en) * | 1987-07-28 | 1988-12-20 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
| WO2002078684A2 (en) * | 2001-03-30 | 2002-10-10 | Sangstat Medical Corporation | Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders |
| CA2475209A1 (en) * | 2002-02-04 | 2003-08-14 | Alfama - Investigacao E Desenvolvimento De Produtos Farmaceuticos Lda. | Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases |
| JP2005533812A (ja) * | 2002-06-21 | 2005-11-10 | ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 一酸化窒素、ヘムオキシゲナーゼ−１、およびヘム分解生成物の薬学的使用 |
| KR100967334B1 (ko) * | 2002-09-09 | 2010-07-05 | 넥타르 테라퓨틱스 | 말단 카르복실산을 가진 수용성 중합체 유도체의 제조 방법 |
| US20070207217A1 (en) * | 2003-02-03 | 2007-09-06 | Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda | Method for treating a mammal by administration of a compound having the ability to release CO |
| JP2007501209A (ja) * | 2003-08-04 | 2007-01-25 | ノースウィック パーク インスティテュート フォー メディカル リサーチ | 一酸化炭素の治療目的での放出のためのボラノカルボネートの使用 |
| US8148356B2 (en) * | 2005-08-24 | 2012-04-03 | Cumberland Pharmaceuticals, Inc. | Acetylcysteine composition and uses therefor |
| WO2007073225A1 (en) * | 2005-12-20 | 2007-06-28 | Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda. | Molybdenum carbonyl complexes for treating rheumatoid arthritis and other inflammatory diseases |
| GB0601394D0 (en) * | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
| AU2007328549A1 (en) * | 2006-12-06 | 2008-06-12 | Alfama - Investigacao E Desenvolvimento De Produtos Farmaceuticos Lda | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
-
2008
- 2008-04-24 US US12/597,665 patent/US20100196516A1/en not_active Abandoned
- 2008-04-24 EP EP08741777A patent/EP2148688A1/en not_active Withdrawn
- 2008-04-24 JP JP2010506110A patent/JP2010525055A/ja active Pending
- 2008-04-24 WO PCT/PT2008/000017 patent/WO2008130261A1/en not_active Ceased